Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01746251
Title Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94304 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Massachusetts General Hospital Boston Massachusetts 02115 United States Details
Memorial Sloan Kettering New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field